| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
B Activation in Human Testicular Apoptosis


From the Program for Developmental and Reproductive
Biology,*
Biomedicum Helsinki, and Hospital for Children and
Adolescents, University of Helsinki, Helsinki; the Wihuri Research
Institute,
Helsinki; and the Department of
Anatomy,
University of Turku, Turku, Finland
| Abstract |
|---|
|
|
|---|
B in
controlling apoptosis prompted us to investigate NF-
B activity in
the normal human testis and its role in testis tissue undergoing
excessive apoptosis in vitro. In electrophoretic
mobility shift assays, low-level constitutive NF-
B
DNA-binding activity was found and, by immunostaining of the
RelA and p50 NF-
B subunits, was localized to Sertoli cell
nuclei. During in vitro-induced testicular
apoptosis, the Sertoli cell nuclear NF-
B levels and whole
seminiferous tubule NF-
B DNA-binding activity increased previous
detection of germ cells undergoing apoptosis. The anti-inflammatory
drug sulfasalazine effectively suppressed stress-induced NF-
B DNA
binding and NF-
B-mediated I
B
gene expression.
Importantly, concomitantly with inhibiting NF-
B,
sulfasalazine blocked germ cell apoptosis. These results suggest that
during testicular stress Sertoli cell NF-
B proteins exert
proapoptotic effects on germ cells, which raises the
possibility that pharmacological inhibition of NF-
B could be a
therapeutic target in transient stress situations involving excessive
germ cell death.
B (NF-
B), a transcription
factor considered to be a major regulator of the immune and stress
responses,3,4
is an interesting candidate for the
regulation of male germ cell apoptosis because there is growing
evidence that this transcription factor has a function in cell
proliferation and apoptosis,4,5
and as recent studies
suggest a role for NF-
B in mammalian spermatogenesis.6
NF-
B is a dimeric DNA sequence-specific transcription factor that is
assembled from two of the five known mammalian Rel/NF-
B subunits
(RelA/p65, RelB, c-Rel, p50, and p52).3,7
In most cells,
the major Rel complex is the p50-RelA heterodimer. In unstimulated
cells, NF-
B dimers remain sequestered in the cytoplasm by inhibitory
I
B proteins, which cover the nuclear localization sequence of
NF-
B and interfere with sequences important for DNA binding.
Stimulation by a variety of extracellular signals leads to degradation
of the I
B.8,9
The liberated NF-
B then rapidly
translocates to the nucleus, where it regulates transcription by
binding to consensus
B sites in the promoters of the target
genes.4
One of the target genes activated by NF-
B is
that encoding I
B
, the best known I
B protein. Newly synthesized
I
B
can enter the nucleus, remove NF-
B from the DNA, and export
the complex back into the cytoplasm.10-12
In this way,
NF-
B limits its own activation.
In the rat testis, the NF-
B complex of RelA and p50 proteins was
found to be constitutively expressed in the nuclei of Sertoli cells at
all stages of spermatogenesis.13
In addition, nuclear
NF-
B expression was elevated in Sertoli cells at stages XIV to VII,
which correlates with the presence of round spermatids, and was also
transiently and stage-specifically found in pachytene spermatocytes and
round spermatids.13
Moreover, in cultured rat Sertoli
cells, an increase in nuclear NF-
B DNA-binding activity and
B-dependent transcription has been shown to be induced by the
cytokine tumor necrosis factor-
(TNF-
).13
As
TNF-
is known to be secreted by round spermatids,14
a
paracrine mechanism has been suggested, in which this TNF-
activates
NF-
B in Sertoli cells, leading to changes in the expression of
Sertoli cell proteins that are able to modulate
spermatogenesis.6
In accord, TNF-
-induced activation of
NF-
B in rat Sertoli cells in vitro leads to up-regulation
of the cAMP-response element-binding protein, which is an important
regulator of a number of cAMP-induced genes and consequently is
suggested to be a regulator of spermatogenesis.15
However,
the physiological role of NF-
B in the testis still remains unclear.
Regarding apoptosis, the NF-
B transcription factors may have both
anti-apoptotic and proapoptotic effects.5
The
anti-apoptotic activities of NF-
B have been observed in certain
nontesticular cells after some external stimuli, such as TNF-
,
ionizing radiation, and chemotherapeutic compounds.16-19
The inhibitory effect of NF-
B on TNF-
- or chemotherapy-induced
apoptosis has also been shown in chemotherapy-resistant
tumors.20
On the other hand, there is growing evidence for
apoptosis-promoting functions of NF-
B. In human embryonic kidney
cells, serum withdrawal induces NF-
B activation and apoptosis, which
can be prevented by the overexpression of a dominant-negative form of
RelA.21
Double-positive
(CD4+CD8+) T cells from
mice overexpressing a dominant-negative form of I
B
are resistant
to activation-induced cell death.22
Furthermore, NF-
B
stimulates the expression of the death-promoting Fas ligand (FasL) in T
cells after T-cell receptor engagement or exposure to DNA-damaging
agents, thus suggesting a proapoptotic role of
NF-
B.23,24
Interestingly, recent evidence indicates
that NF-
B may have either proapoptotic or anti-apoptotic effects in
the same cell type, depending on the death-inducing
stimulus.25
Thus, whether NF-
B promotes or inhibits
apoptosis seems to depend on the specific cell type and the type of the
inducer. Therefore, to understand the role of NF-
B in different
physiological situations, the behavior of this transcription factor in
different apoptosis models needs further characterization. In the
testis tissue, studies on NF-
B have been limited to characterization
of its expression. Our preliminary experiments suggested an association
between NF-
B activation and apoptosis in the human
testis,26
but the role of this transcription factor in
testicular apoptosis remains unresolved.
In the present study, we aimed at characterizing the role of NF-
B in
human testicular apoptosis. As no studies on NF-
B expression in the
human testis were available, we first studied the constitutive
expression and DNA-binding activity of the NF-
B proteins in normal
adult human testis. We then explored the induction of NF-
B
DNA-binding activity and nuclear translocation during human testicular
apoptosis, using our established in vitro tissue culture
model.27
Finally, we tested whether this activation of
NF-
B can be pharmacologically modulated and evaluated the effects of
NF-
B inhibition on testicular germ cell survival.
| Materials and Methods |
|---|
|
|
|---|
Testis tissue was obtained from 12 men aged 59 to 88 years undergoing orchidectomy as treatment for prostate cancer. They had not received hormonal, chemotherapeutic, or radiotherapeutic treatment for the cancer before the operation. They had no endocrinological disease and none of them had suffered from cryptorchidism. The operations were performed between March 2000 and January 2001 at the Department of Urology, Helsinki University Central Hospital (Helsinki, Finland). The Ethics Committees of the Hospital for Children and Adolescents and the Department of Urology, University of Helsinki, approved the study protocol.
Tissue Culture and Treatments
Apoptosis of the human testicular germ cells was induced in
vitro by incubating segments of seminiferous tubules under
serum-free culture conditions. We cultured segments of seminiferous
tubules, rather than isolated germ cells, to maintain the physiological
contact between the Sertoli cells and the germ cells. The testis tissue
was microdissected on a Petri dish containing tissue culture medium
(Nutrient mixture Hams F10; Gibco Europe, Paisley, UK) supplemented
with 0.1% human albumin (Sigma Chemical Co., St. Louis, MO) and 10
µg/ml gentamicin (Gibco). Segments of seminiferous tubules (
2 mm
in length) were isolated and transferred to culture plates containing
the same tissue culture medium and cultured at 34°C in a humidified
atmosphere containing 5% CO2.
Sulfasalazine (SS) (Fluka Chemie Ag, Buchs, Switzerland) was dissolved
in culture medium at 5 mmol/L immediately before use. Acetyl salicylic
acid (ASA) (Sigma) was dissolved in 0.05 mol/L of Tris-HCl, pH 7.5, to
prepare 1 mol/L of stock solution and used at a concentration of 5
mmol/L. n-Acetyl-L-cysteine (NAC)
(Sigma) was prepared as 1 mol/L of stock solution in distilled water,
with the pH adjusted to 7.5 with NaOH, and used at 100 mmol/L. The
NF-
B SN50 peptide (Biomol Research Laboratories, Plymouth Meeting,
PA) was used at 10 µg/ml.
Cytoplasmic and Nuclear Protein Extractions
Seminiferous tubules were gently homogenized with a tight-fitting Potter-Elvehjem homogenizer into ice-cold hypotonic buffer A (50 mmol/L HEPES, pH 7.4, 10 mmol/L KCl, 1 mmol/L ethylenediaminetetraacetic acid, 1 mmol/L dithiothreitol, 0.2 mmol/L phenylmethylsulfonyl fluoride, 1 µg/ml pepstatin A, 1 µg/ml leupeptin, 0.5% Nonidet P-40), and cytoplasmic and nuclear protein extracts were prepared as previously described.28 Protein concentrations were determined by the Bradford method, using the Bio-Rad DC protein assay (Bio-Rad Laboratories, Hercules, CA). The protein extracts were stored in aliquots at -80°C until used for electrophoretic mobility shift assays (EMSAs) or Western blotting.
EMSA
DNA probe containing a consensus
B enhancer element (5'-AGT TGA
GGG GAC TTT CCC AGG C-3') was purchased from Santa Cruz (sc-2505; Santa
Cruz Biotechnology, Inc., Santa Cruz, CA). The probe was 5'-end-labeled
with [
-32P]ATP using T4 polynucleotide
kinase (Promega Corp., Madison, WI). Testicular nuclear protein
extracts (10 µg) or control nuclear protein extracts [Jurkat T
cells, sc-2132 (Santa Cruz); KNRK cells, sc-2141 (Santa Cruz); K562
cells, sc-2130 (Santa Cruz); and LPS-stimulated human monocyte-derived
macrophages (5 to 10 µg)] were incubated on ice for 10 minutes with
2 µg poly(dI-dC)(dI-dC) (Amersham Pharmacia Biotech, Piscataway, NJ)
in 50 mmol/L HEPES, pH 7.6, 10% glycerol (v/v), 225 mmol/L KCl, 1
mmol/L ethylenediaminetetraacetic acid, 2.5 mmol/L dithiothreitol, 1
mmol/L MgCl2, 0.75 mmol/L phenylmethyl sulfonyl
fluoride, and 1.5 µmol/L leupeptin. A 5'-end-labeled probe (15,000 to
30,000 cpm) was then added, and incubation was continued at room
temperature for 30 minutes. In the competition experiments, a 100-fold
molar excess of unlabeled probe or unlabeled mutated probe (sc-2511,
Santa Cruz) was added before the labeled probe. Reaction products were
separated on 4% polyacrylamide gels run in 22.5 mmol/L of Tris-borate
and 0.5 mmol/L of ethylenediaminetetraacetic acid at 200 V at room
temperature. After electrophoresis, the gels were dried and visualized
by autoradiography. In the supershift assays, 2 µg of
affinity-purified polyclonal antibodies were added after binding
reactions and incubation was further continued for 1 hour at room
temperature. The antibodies for the supershift assays were purchased
from Santa Cruz (RelA/p65, sc-109X; p50, sc-7178X; c-Rel, sc-272X; p52,
sc-298X; RelB, sc-226X).
Immunohistochemistry
Immunostainings of the RelA (p65) and p50 NF-
B subunits were
performed on paraffin-embedded sections of formalin-fixed adult human
testis tissue or isolated seminiferous tubules, or on squash
preparations of human seminiferous tubules. For the squash
preparations, small segments of human seminiferous tubules (
1 mm in
length) were squashed under coverslips to produce a monolayer of cells,
and the preparations were fixed as previously described.29
Paraffin sections were incubated at 60°C for 30 minutes and
deparaffinized in xylene. Both paraffin sections and squash
preparations were then rehydrated, permeabilized by microwaving at high
power for 5 minutes in citrate buffer (10 mmol/L citrate, pH 6.0),
washed, and blocked with blocking solution [phosphate-buffered saline
(PBS) containing 5% goat normal serum, 3% bovine serum albumin, and
0.1% Tween 20] for at least 30 minutes at room temperature. Our
preliminary experiments revealed unspecific staining for endogenous
peroxidases only in the erythrocytes of the testicular capillaries
found in paraffin sections of testis tissue, and therefore, endogenous
peroxidases were not blocked. RelA and p50 proteins were detected with
affinity-purified polyclonal antibodies to human RelA (sc-109, Santa
Cruz) or p50 (sc-7178X, Santa Cruz). Both antibodies were used at 0.02
to 0.04 µg/ml for the paraffin sections and at 0.4 µg/ml for the
squash preparations. The primary antibodies were added to the samples
in blocking solution and incubation was performed overnight at 4°C.
After incubation, the slides were washed in PBS. The primary antibodies
were detected using biotin-conjugated goat anti-rabbit IgG from the
ABC-Elite kit (Vector Laboratories, Inc., Burlingame, CA) followed by
incubation with ABC solution. For location of the secondary antibody,
0.05% diaminobenzidine substrate (Sigma) was added. For the negative
controls, the primary antibodies were replaced with nonspecific rabbit
IgG (Sigma). After the staining protocols, light counterstaining was
performed with hematoxylin, and the samples were dehydrated and
mounted.
Southern Blot Analysis of Apoptotic DNA Fragmentation
Genomic DNA was extracted from frozen segments of human seminiferous tubules, using the Apoptotic DNA Ladder Kit (Roche Molecular Biochemicals, Mannheim, Germany), as described.30 DNA was quantified spectrophotometrically (absorbance at 260 nm), and 1 µg of the total DNA from each sample was subjected to 3'-end-labeling with digoxigenin-dideoxy-UTP (Dig-dd-UTP; Roche) by the terminal transferase (Roche) reaction. The DNA samples were then electrophoresed on 2% agarose gels, blotted onto nylon membranes, and crosslinked to the membranes by UV irradiation. The membranes were washed and blocked with 1% Blocking reagent (Roche) in maleic buffer (100 mmol/L maleic acid, 150 mmol/L NaCl, pH 7.5) for 30 minutes at room temperature. The 3'-end-labeled DNA on the membranes was localized with alkaline phosphatase-conjugated anti-digoxigenin antibody (Anti-Digoxigenin-AP; Roche), and the bound antibody was detected by the chemiluminescence reaction (CSPD; Roche) as described.27
In Situ End Labeling (ISEL) of Apoptotic DNA
Squash preparations of human seminiferous tubules were rehydrated, washed in distilled water, and permeabilized by microwaving at high power for 5 minutes in citrate buffer (10 mmol/L citrate, pH 6.0). After incubation for 10 minutes with terminal transferase reaction buffer (1 mol/L potassium cacodylate, 125 mmol/L Tris-HCl, and 1.25 mg/ml bovine serum albumin, pH 6.6), the apoptotic DNA was 3'-end-labeled with Dig-dd-UTP (Roche) for 1 hour at 37°C by the terminal transferase reaction. For the negative controls, the terminal transferase enzyme was replaced with the same volume of distilled water. The preparations were then blocked with blocking solution [2% Blocking reagent (Roche), in 150 mmol/L NaCl, 100 mmol/L Tris-HCl, pH 7.5], followed by location of the Dig-dd-UTP with the peroxidase-conjugated anti-digoxigenin antibody (Anti-Digoxigenin-POD, Roche). For detection of the antibody, 0.05% diaminobenzidine substrate (Sigma) was added. Light counterstaining was performed with hematoxylin, after which the samples were dehydrated and mounted.
Western Blotting
Western blotting of the I
B
was performed on cytoplasmic
protein extracts of seminiferous tubules. Proteins (15 µg) were
loaded into 10% sodium dodecyl sulfate-polyacrylamide gels and
electrophoresis was performed at 180 V. The proteins were transferred
to polyvinylidene difluoride membranes (Immobilon-P; Millipore Corp.,
Bedford, MA) by electrophoresis for 2 hours at 4°C in transfer buffer
(26 mmol/L Tris, 192 mmol/L glycine, 10% methanol) at 100 V. The
transfer was checked by staining with 0.2% Ponceau S in 3%
trichloroacetic acid. I
B
protein on the membranes was detected
using affinity-purified polyclonal antibodies to human I
B
(sc-371
and sc-847, Santa Cruz) at 0.2 µg/ml. The specificity of the band
detected with either of the two antibodies was confirmed by
preabsorption experiments with a blocking peptide (sc-371P, Santa
Cruz). FasL was detected with an anti-human FasL monoclonal antibody
(Transduction Laboratories, Lexington, KY). The primary antibodies were
followed with peroxidase-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA) or peroxidase-conjugated
goat anti-mouse IgG (DAKO Corp. A/S, Glostrup, Denmark). The bound
secondary antibody was located with the ECL detection kit (Amersham,
Arlington Heights, IL). After detection of the proteins under
investigation, the membranes were washed and, as a loading control,
probed with an antibody to
-tubulin (Sigma).
Quantitative Analysis of X-Ray Films
The X-ray films exposed to chemiluminescence (Southern blots) or
autoradiography (EMSA; see Figure 2C
) were scanned with a tabletop
scanner (Hewlett Packard ScanJet 6300C) and the digital image
was analyzed with the Gel plot 2 macro for Scion Image ß 4.0.2 (Scion
Corp., Frederick, MD) analysis software. For the Southern blots, the
digitized quantification of the low molecular weight DNA fragments
(<1.3 kB) in the sample cultured for 5 hours (or 10 hours in time
course analysis of nuclear apoptosis; see Figure 2C
) without treatments
was taken as 1.0 (100% apoptosis), and the amounts of low molecular
weight DNA fragments in the other samples were expressed in relation to
this. For time course analysis of NF-
B activation (EMSA; see Figure 2C
), the digitized quantification of the specific NF-
B bands in the
sample cultured for 5 hours was set as 1.0, and the intensities of the
bands in other samples were expressed in relation to this.
|
The experiments for Southern blot analysis of the effects of SS,
ASA, NAC, or SN-50 on apoptotic DNA fragmentation were repeated on at
least three independent occasions. Quantitative data represent low
molecular weight DNA (integrated optical density from scanned X-ray
films). Data obtained from 3 to 10 replicate experiments (mean ±
SEM) were analyzed by one-way analysis of variance, and when
significant differences were found, this was followed by comparison of
the groups with two-tailed unpaired Students t-test.
P < 0.05 was considered statistically significant.
Data demonstrating the time courses of I
B
degradation, NF-
B
DNA-binding activity, or nuclear apoptosis are representative of two
independent experiments. Three independent experiments were conducted
in which the effect of SS on the expressions of I
B
or FasL were
studied by Western blotting, and at least three independent experiments
were conducted in which the effects of SS, ASA, NAC, or SN-50 on
NF-
B DNA-binding activity were studied by EMSA.
| Results |
|---|
|
|
|---|
B Activity in the Adult Human Testis
To explore the constitutive NF-
B activity in the adult human
testis, the DNA-binding activity of the
B-binding proteins was first
studied by EMSAs, using nuclear protein extracts from freshly isolated
human seminiferous tubules and a DNA probe containing a consensus
B-binding sequence. Consistent with our previous
results,26
three DNA-protein complexes designated A, B,
and C (Figure 1A)
, were found. Band B was
clearly seen, whereas bands A and C were poorly visible in the basal
situation before exposure of the seminiferous tubules to
apoptosis-inducing conditions. Competition experiments confirming the
specificity of binding to the
B oligonucleotide are presented in
Figure 2
. At the bottom of the gel we
observed a band that seemed to represent an unspecific complex that was
not eliminated by the unlabeled competitor and that was associated with
the
B oligonucleotide because it was present not only in nuclear
extracts of seminiferous tubules but also in control samples tested
including nuclear extracts of LPS-stimulated human macrophages, Jurkat
T cells, KNRK cells, or K562 cells. As demonstrated by the supershift
assay, the NF-
B subunits RelA (p65) and p50 participated in the
formation of the observed DNA-protein complexes (Figure 1A)
. We also
tested antibodies against c-Rel, p52, and RelB, but we did not find
supershifts of the basal complexes with any of these antibodies. Under
similar conditions these antibodies were found to bind to the
corresponding DNA-protein complexes in EMSAs of control nuclear
extracts (K562 for c-Rel, Jurkat for p52, and LPS-stimulated human
monocyte-derived macrophage and KNRK for RelB) (data not shown).
|
B. In the majority of the
tubules, strong positive staining for RelA was found in the cytoplasm
of some spermatogonia and early meiotic spermatocytes (Figure 1B, a and b)
B
expression in the human testis was not attempted. It should be noted
that, on account of the very large volume of the Sertoli cell cytoplasm
and its partial rupture during sample preparation, direct comparison
between Sertoli cell cytoplasmic and Sertoli cell nuclear or germ cell
cytoplasmic staining is difficult. Thus, light immunostaining
surrounding the Sertoli cell nuclei and germ cells most likely
represents cytoplasmic expression of RelA in the Sertoli cells. A
similar staining pattern was observed with an antibody against p50.
When the primary antibody was replaced with nonspecific rabbit IgG,
there was no specific staining (negative control, shown in Figure 4
|
B during in Vitro-Induced
Testicular Apoptosis
The activation of NF-
B during testicular apoptosis was studied
in our established in vitro model.27
As shown
in Figure 2A
, incubation of segments of human seminiferous tubules
under serum-free culture conditions resulted in induction of apoptotic
DNA fragmentation within 5 hours. Apoptosis had further increased at 10
hours of culture. In the same tubules, NF-
B DNA-binding activity had
strongly and rapidly (within 30 minutes) increased from the basal level
and it remained at this elevated level throughout the culture (Figure 2B)
. Especially band A in EMSA was markedly intensified during
induction of testicular apoptosis (Figure 2B)
. We therefore concluded
that NF-
B activation occurs very early as compared with nuclear
apoptosis (Figure 2)
.
NF-
B Activation Is Induced in Sertoli Cells whereas Apoptotic
Cell Death Occurs in Germ Cells
To study the site of NF-
B activation in the human seminiferous
epithelium, we first tested the subunit composition of the inducible
DNA-protein complexes by supershift assays using nuclear protein
extracts from seminiferous tubules cultured for 2.5 hours in serum-free
conditions. As demonstrated in Figure 3
,
complexes A and B, representing nuclear proteins specifically binding
to the
B consensus oligonucleotide, were retarded by the anti-p50
and anti-RelA antibodies, but not by the other antibodies tested
(c-Rel, p52, RelB, and an unrelated control antibody), indicating that
the inducible NF-
B in the human testis is composed of the p50 and
RelA subunits. The ability of the antibodies against c-Rel, p52, and
RelB to bind to the corresponding DNA-protein complexes was confirmed
in EMSAs of control nuclear extracts (K562 for c-Rel, Jurkat for p52,
and LPS-stimulated human monocyte-derived macrophage and KNRK for RelB)
(data not shown).
|
B expression (Figure 4A, b)
B proteins was not observed in the spermatogonia or early meiotic
spermatocytes, in which cytoplasmic staining for the RelA and p50 was
intense in the 0-hour samples. Thus, the site of NF-
B activation, as
indicated by nuclear translocation of the RelA and p50 proteins, was
the Sertoli cells. The significance of the positive cytoplasmic NF-
B
staining in the early meiotic germ cells remains unclear.
When considering the potential role of NF-
B in the regulation of
testicular apoptosis, it was of interest to determine whether NF-
B
activation occurred in the same cell types where apoptosis took place.
Therefore, we performed RelA immunostaining and ISEL of apoptotic DNA
fragments using squash preparations of human seminiferous tubules that
had been exposed to apoptosis-inducing conditions or that had been
cultured in serum-free conditions to induce apoptotic cell death
(Figure 4B)
. We used squash preparations rather than paraffin sections
1) because of the lack of false-positive labeling, which may be caused
after accidental formation of free DNA 3'-ends during permeabilization
of paraffin sections, we considered the results of ISEL more reliable,
and 2) because in squash preparations, the nuclei of the cells maintain
their characteristic morphology better, allowing more accurate
identification of the individual cell types. In agreement with the
results in the paraffin sections, no nuclear RelA immunostaining was
observed in the majority of the segments of tubules squashed
immediately after the orchidectomy (Figure 4B, a)
, whereas, in the
samples cultured for 2.5 hours, a great number of positively staining
Sertoli cell nuclei were found (Figure 4B, b and c)
. In the squash
preparations, the identification of Sertoli cell nuclei was based on
their typical size and shape and on the presence of a characteristic
nucleolus. In contrast, in the ISEL analysis, apoptotic DNA
fragmentation was predominantly observed in late meiotic and
postmeiotic germ cells, whereas, the Sertoli cell nuclei remained
negative (Figure 4B
; d, e, and f). This result is in agreement with the
results of our previous studies31,32
in which we have
shown with ISEL and electron microscopy that the cells undergoing
apoptosis in the present in vitro model are mainly
spermatocytes and spermatids.
Inhibition of Testicular NF-
B Induction and Apoptosis by SS
To evaluate the effects of NF-
B activation on testicular germ
cell survival, we next tested the ability of previously reported
NF-
B inhibitors to modulate NF-
B activation and apoptotic germ
cell death in our in vitro model. Both testicular apoptosis
and NF-
B induction were effectively blocked by the anti-inflammatory
drug SS (Figure 5)
. A 5 mmol/L
concentration of SS inhibited apoptotic DNA fragmentation during 5
hours of culture by 87% (P < 0.001) (Figure 5A)
and concomitantly retained NF-
B DNA-binding activity at the
basal (0 hour) level after 2.5 hours (Figure 5B)
and 5 hours (data not
shown) in three independent experiments. Interestingly, effective
inhibition of apoptotic DNA fragmentation by SS was still observed
after 48 hours of culture in two independent experiments (data not
shown). In one experiment, culture of seminiferous tubules was
continued for 4 days, after which SS still prevented apoptotic DNA
laddering but some smearing typical for necrosis was observed in
SS-treated tubules (data not shown). A NF-
B inhibitory peptide SN-50
(10 µg/ml) also slightly inhibited testicular apoptosis (24%,
P = 0.01), but an inhibitory effect of this peptide on
NF-
B activation could not be reliably detected with EMSAs (data not
shown). Other previously reported NF-
B inhibitors, ASA and NAC, were
also found to be effective inhibitors of testicular apoptosis (Figure 5A)
. Apoptotic DNA fragmentation was reduced by 44%
(P < 0.05) with ASA at 5 mmol/L and by 87%
(P = 0.001) with NAC at 100 mmol/L. However,
although capable of inhibiting apoptosis, ASA and NAC had no effect on
NF-
B DNA binding (Figure 5B)
. Thus, the anti-apoptotic effects of
ASA and NAC seem to be mediated by mechanisms other than NF-
B
inhibition. In contrast, the strong apoptosis-blocking effect of SS
may, at least partly, be mediated via NF-
B inhibition.
|
SS-Mediated Inhibition of Sertoli Cell NF-
B Activation at the
Level of Nuclear DNA Binding
Because SS in certain cell types has previously been reported to
inhibit NF-
B activity by inhibiting I
B
degradation,33,34
we wished to know whether the same
inhibitory mechanism functions in the seminiferous epithelium. Western
blot analysis of I
B
protein in the seminiferous tubules showed
that, in agreement with the rapid increase in the NF-
B DNA-binding
activity, I
B
was readily degraded after the onset of serum
withdrawal (Figure 6A, a)
. Even during 10
hours of culture, however, the I
B
protein did not completely
disappear; the lowest level was observed at 2.5 hours, after which the
expression of I
B
gradually increased slightly. This is likely to
be explained by the known ability of activated NF-
B to stimulate
I
B
gene transcription. I
B
degradation was not prevented in
the samples treated with 5 mmol/L of SS (Figure 6A, b)
, thus suggesting
that SS inhibits NF-
B activation at a level distal to I
B
degradation. Interestingly, Western blotting revealed the complete
disappearance of the I
B
protein in the SS-treated tubules after 5
hours of culture (Figure 6A, b)
, suggesting that SS prevented the
NF-
B-induced synthesis of new I
B
protein. Similar results were
obtained in three independent experiments and with two different
antibodies to human I
B
. Equal loading of the samples was
confirmed by reprobing the blots with an antibody against
-tubulin.
In agreement with the results of the I
B
Western blots, RelA
immunostaining of SS-treated seminiferous tubules showed that nuclear
translocation of the RelA protein in the Sertoli cells was not
prevented by SS (Figure 6B)
. Thus, in the present apoptosis model, SS
seems to inhibit NF-
B at the level of DNA binding in the nucleus.
|
B
Finally, because the promoter of the gene encoding the Fas ligand
(FasL) is known to contain NF-
B-binding sites,24,35
and
because the regulation of this gene has been suggested to be a
potential target for NF-
B in the testis, we tested the effect of the
SS-mediated NF-
B blockade on the expression of the FasL protein in
Western blot analysis. Despite the effective inhibition of NF-
B
activation, SS had no effect on the protein expression of the FasL
after 2.5 hours and 5 hours culture (data not shown), suggesting that
NF-
B does not regulate testicular FasL expression during
stress-induced apoptosis.
| Discussion |
|---|
|
|
|---|
B in regulating rodent spermatogenesis,6
but
the physiological significance of NF-
B in the testis tissue has
remained unclear. Moreover, studies on NF-
B expression and activity
in the human testis have been limited to our preliminary findings on
NF-
B DNA-binding activity in isolated human seminiferous
tubules.26
In view of the growing evidence on the role of
NF-
B in controlling apoptosis,5
and the importance of
apoptotic cell death during spermatogenesis,2
we set out
to elucidate NF-
B activation during testicular apoptosis and its
consequences. In the present study we have shown that constitutively
active nuclear NF-
B exists at low levels in the Sertoli cells of the
human testis. Furthermore, using cultured human seminiferous tubules as
a model,27
we demonstrated that nuclear NF-
B expression
and DNA binding in Sertoli cells increases rapidly during in
vitro-induced apoptosis of male germ cells. Finally, we found that
pharmacological inhibition of testicular NF-
B activation was
associated with effective suppression of germ cell death.
Our first aim was to describe the constitutive expression and
DNA-binding activity of NF-
B transcription factors in normal adult
human testis. Consistently with the results for the rat
testis,13
we found low basal NF-
B DNA-binding activity,
which, by immunostaining of the RelA and p50 subunits, was localized to
Sertoli cells. However, in contrast to the rat testis, in which Sertoli
cells were found to express nuclear NF-
B at all stages of
spermatogenesis,13
only a few segments of the seminiferous
tubules contained positively staining Sertoli cell nuclei in the human
testis. Moreover, no germ cells showing nuclear NF-
B were found,
which contrasts with the previously observed stage-dependent expression
of nuclear NF-
B in the late meiotic and postmeiotic germ cells of
the rat testis.13
However, intense cytoplasmic staining
for NF-
B was found in the spermatogonia and early meiotic germ cells
of the human testis. As no nuclear translocation of this cytoplasmic
NF-
B was observed during in vitro-induced testicular
stress, the physiological significance of this finding remains unclear.
In light of the importance of the stable pool of immature germ cells
for continuous spermatogenesis,36
it can be hypothesized
that the extensive deposition of NF-
B in the cytoplasm of the
spermatogonia and immature spermatocytes can be used for rapid nuclear
translocation and transcriptional activation of protective genes on
certain stimuli.
A strong and rapid increase in nuclear NF-
B DNA-binding activity was
observed in human seminiferous tubules cultured in serum-free
conditions to induce testicular apoptosis. NF-
B induction was
already evident after 30 minutes of culture, but clear apoptotic DNA
fragmentation only appeared in Southern blot analysis after 5 hours of
culture. The very early activation of NF-
B, as compared with nuclear
apoptosis, led us to suggest a regulatory role for NF-
B in
testicular apoptosis. In this regard, it was of interest to know
whether NF-
B activation and apoptosis occur in the same cell types.
Increased positive nuclear immunostaining for RelA and p50 was observed
in the Sertoli cells of all of the tubules cultured under serum-free
conditions, indicating that the site of NF-
B activation was in the
Sertoli cells. However, ISEL analysis of apoptotic DNA fragmentation
revealed that apoptosis was induced in late meiotic and postmeiotic
germ cells whereas the Sertoli cells survived. Thus, it could be
hypothesized that during severe stress NF-
B activation in Sertoli
cells functions to protect the Sertoli cells themselves and, to keep
the germ cell population small enough for the limited nursing capacity
of the Sertoli cells, simultaneously induces transcription of Sertoli
cell gene(s) that are able to mediate germ cell death. This would be a
reasonable way for the Sertoli cells to act, because they are essential
for functional spermatogenesis1
and they are terminally
differentiated cells with no capacity for renewal. Interestingly,
induction of testicular NF-
B DNA-binding activity was completely
blocked by the anti-inflammatory aminosalicylate drug SS, which has
also been shown to specifically inhibit NF-
B activation in colon
epithelial cells and in Jurkat T cells.33,34
Concomitantly, germ cell apoptosis was effectively suppressed,
supporting the hypothesized role of NF-
B as one of the factors
controlling stress-induced germ cell death. However, Sertoli cells
survived despite SS treatment, which does not support the view that
Sertoli cell survival depends on their NF-
B activation. It also
suggests that the apoptotic death of meiotic and postmeiotic male germ
cells can be pharmacologically modulated by NF-
B inhibitory drugs
with no hazardous effects on Sertoli cells.
SS has been previously reported to inhibit NF-
B activation by
directly inhibiting the I
B kinases
and ß, which leads to
inhibition of the I
B
degradation.34
Interestingly,
in the present study, SS inhibited neither I
B
degradation nor
nuclear translocation of the RelA subunit, but prevented the formation
of new I
B
protein, which may indicate a decrease in
NF-
B-mediated transcriptional activation of the I
B
gene. That
the cytoplasmic NF-
B in some immature germ cells did not translocate
into the nucleus despite disappearance of the I
B
may indicate
that the type of I
B in these cells is other than I
B
. Indeed,
high levels of I
Bß and I
B
mRNA have been found in the
testis,37,38
which suggests that these forms of I
B
participate in the regulation of testicular NF-
B. Thus, the
mechanism by which SS appears to inhibit NF-
B DNA binding in the
present apoptosis model differs from the previously documented
SS-mediated inhibition of the I
B kinases, and remains to be
clarified. Interestingly, the DNA-binding and transactivating
capacities of RelA and p50 are also positively regulated by selective
phosphorylation of these proteins.39
That the
phosphorylation of the NF-
B proteins can be pharmacologically
modulated without affecting I
B phosphorylation and degradation is
exemplified by the finding that mesalamine, an analogue of SS that
lacks an azo-group present in SS, stimulates interleukin-1-induced
NF-
B-dependent transcription in colon epithelial cells by
selectively inhibiting RelA phosphorylation and has no effect on I
B
degradation, NF-
B nuclear translocation, or NF-
B DNA
binding.40
As the DNA binding of RelA and p50 may also be
disturbed by their hypophosphorylation39
and as different
NF-
B-inducing stimuli may cause phosphorylation of NF-
B proteins
at unique sites,41,42
which possibly differentially
affects their DNA binding, selective inhibition of RelA or p50
phosphorylation could be the mechanism by which SS blocks NF-
B DNA
binding in human testicular cells under the conditions induced in the
present model. Because of the general anti-inflammatory action of SS,
other simultaneous NF-
B-independent pathways affecting either
Sertoli cells or germ cells directly may also contribute to the
SS-mediated germ cell survival. In this context, apoptosis inhibition
because of the anti-oxidative properties of SS43,44
seems
unlikely, because I
B
degradation, which in many cell types is
known to be blocked by anti-oxidative compounds,45
was not
prevented. However, this possibility cannot be completely ruled out,
because a delayed reactive oxygen species-dependent signaling pathway,
which is required for NF-
B transcriptional activation but is
separable from that required for its nuclear translocation and DNA
binding, has also been described.46
Because of the complex cell-specific network of interacting proteins in
the NF-
B signaling pathway, diverse compounds may act at multiple
levels to inhibit NF-
B activation and, importantly, the ability of a
given compound to modulate NF-
B activity depends on the cell type
and the NF-
B-inducing signal.45
Therefore, in parallel
to SS, we tested the ability of other compounds, previously reported to
inhibit NF-
B in other cellular systems, to suppress testicular
NF-
B activity and apoptosis. Of these compounds, a
NF-
B-inhibitory peptide, SN-50, which competes for the nuclear
transport system with NF-
B,47
also slightly inhibited
testicular apoptosis. A concomitant weak inhibition of NF-
B DNA
binding in SN-50-treated seminiferous tubules was observed in some
experiments, but perhaps because of the large amount of inhibition
needed for clear results in the EMSA experiments, this inhibitory
effect of the SN-50 peptide on NF-
B activation was not reliably
detected in all experiments. In contrast, ASA48
and
NAC49
effectively suppressed testicular apoptosis, but had
no effect on NF-
B activation. Thus, in the present study, the
anti-apoptotic effects of ASA and NAC seem to be mediated by mechanisms
that do not involve Sertoli cell NF-
B inhibition and may affect germ
cells directly. Although this result could be interpreted as showing
that NF-
B activation does not play an obligatory role in the
induction of testicular apoptosis, it more likely reflects the
presence of many compensatory or parallel apoptotic pathways in the
testis. The importance of apoptotic cell death for functional
spermatogenesis would support the idea that apoptosis induction in the
testis does not rely on a single pathway.
Finally, we wished to find out whether the testicular expression
of the death-promoting cytokine FasL is regulated by NF-
B, because
this cytokine is known to play an important role in the control of
testicular apoptosis,50-52
and because its expression has
been shown to be directly regulated by NF-
B in certain forms of
apoptosis.23,24
We have previously shown that the
expression of the FasL is up-regulated during in
vitro-induced testicular apoptosis.26
If this was
because of NF-
B-dependent transcription of the gene encoding the
FasL, then SS, which effectively blocks NF-
B DNA-binding activity,
should affect the expression of the FasL. However, we found no effect
of SS on the expression of the FasL suggesting that, at least in the
present in vitro model, NF-
B does not regulate testicular
FasL gene expression during stress-induced apoptosis. This result
agrees with our previous results showing that the cytokine TNF-
inhibited testicular apoptosis and concomitantly down-regulated the
expression of the FasL, but had no effect on the inducible NF-
B
activity.26
Thus, in a testicular stress situation caused
by external disturbances, the NF-
B- and FasL-mediated pathways seem
to function in parallel to regulate testicular germ cell death.
In the present study, we used an in vitro tissue culture for
studying NF-
B activation in human testicular apoptosis. Our culture
model, like all in vitro models, has limitations. NF-
B
activation depends on the type of stressor and the culture of
seminiferous tubules under serum-free conditions involves not only
serum deprivation but also relative hyperoxia because of high partial
oxygen pressure in normal atmosphere as compared with that found in
peripheral organs such as the testis. Thus, the apoptotic pathways
induced in the present model are potentially multiple and, accordingly,
there may also be multiple inducers of NF-
B. Moreover, various
stimuli may differentially activate NF-
B in different types of
cells. It would be interesting to study NF-
B activity after either
specific Sertoli cell toxicants, such as mono-(2-ethylhexyl)phthalate
or 2,5-hexanedione,53,54
or disturbers of germ cells such
as radiation.55,56
However, the culture conditions are
difficult to optimize so that no spontaneous germ cell apoptosis
occurs, which is a prerequisite for conduction of such experiments.
Furthermore, using those kinds of treatments in vivo is
virtually impossible in humans. Moreover, because of the potential
species specificity of cellular responses, results obtained from animal
studies do not necessarily apply to humans. Finally, because the
contacts between Sertoli cells and germ cells play an important role in
testicular physiology and pathology, culturing isolated cells is
inappropriate. Therefore, we feel that despite its limitations, the
present in vitro model, which maintains the physiological
contacts between the cells of the seminiferous epithelium, gives the
best available way to detect human testicular apoptotic mechanisms
involving interaction between different cell types, such as is
presented here, or has been shown for FasL-mediated testicular germ
cell apoptosis.50
The present culture system models a
situation in which human testicular homeostasis is threatened,
demonstrates how different types of cells in the seminiferous
epithelium may act during severe stress, and gives the opportunity to
study the effects of pharmacological modulation of stress-induced
apoptosis in the human testis. Here we have found that the in
vitro-induced death of male germ cells can be effectively
suppressed by SS treatment. Our finding is supported by reports of
reversible infertility and sperm abnormalities, including abnormally
large numbers of immature germ cells in the sperm, in men treated with
SS for inflammatory bowel diseases.57-61
This finding
suggests that SS affects germ cell maturation and apoptosis also
in vivo. Moreover, the reversibility of the infertility
supports our observation that only the apoptotic death of the germ
cells in later phases of maturation is affected by the SS treatment,
leaving the Sertoli cells and the immature germ cells undisturbed and
potentially capable of functional spermatogenesis after cessation of
the treatment.
In conclusion, we have shown that constitutive NF-
B
DNA-binding activity in the Sertoli cells of the human testis was
strongly and rapidly increased during in vitro-induced
testicular apoptosis. Interestingly, apoptotic death occurred in
maturing germ cells, whereas the Sertoli cells containing the inducible
NF-
B survived. Thus, the stress-induced NF-
B nuclear
translocation in Sertoli cells could be hypothesized to induce the
transcription of genes encoding factors involved in the regulation of
germ cell death. Such a mechanism would serve to maintain the
sufficiency of the testicular environment for functional
spermatogenesis. The role of NF-
B as one of the important factors
regulating male germ cell apoptosis was supported by the finding that
both testicular NF-
B activation and germ cell death were effectively
suppressed by a previously reported NF-
B inhibitor and established
clinical drug SS. Although the tissue culture model used in the present
study induces an extreme stress situation in the seminiferous tubules,
it may represent a model showing how different cell types in the
seminiferous epithelium react during the more subtle stress situations
occurring in vivo. Moreover, the results obtained with SS
raise the possibility that pharmacological inhibition of NF-
B could
be a therapeutic target in transient stress situations involving
excessive apoptosis of male germ cells.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
Supported by the Helsinki Biomedical Graduate School, University of Helsinki; the Foundation for Pediatric Research, Finland; and the Sigrid Juselius Foundation, Finland.
Accepted for publication October 4, 2001.
| References |
|---|
|
|
|---|
B and I
B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649683
B transcription factors. Oncogene 1999, 18:6853-6866[Medline]
B transcription factors. Oncogene 1999, 18:6910-6924[Medline]
B signaling pathway. Mol Cell Endocrinol 1999, 157:1-9[Medline]
B signal transduction pathway: introduction. Oncogene 1999, 18:6842-6844[Medline]
B proteins: structure, function and regulation. Semin Cancer Biol 1997, 8:75-82[Medline]
B is activated: the role of the I
B kinase (IKK) complex. Oncogene 1999, 18:6867-6874[Medline]
B controls expression of inhibitor I
B
: evidence for an inducible autoregulatory pathway. Science 1993, 259:1912-1915
B
promotes active transport of NF-
B from the nucleus to the cytoplasm. J Cell Sci 1997, 110:369-378[Abstract]
B
is mediated by the second ankyrin repeat: the I
B
ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol Cell Biol 1998, 18:2524-2534
B in mammalian testis. Mol Endocrinol 1998, 12:1696-1707
in mouse spermatogenic cells. Endocrinology 1993, 133:389-396[Abstract]
B induces cAM